Clinical Trials Logo

C-section clinical trials

View clinical trials related to C-section.

Filter by:
  • None
  • Page 1

NCT ID: NCT04134819 Recruiting - C Section Clinical Trials

Missing Microbes in Infants Born by Cesarean Section

MiMIC
Start date: July 1, 2019
Phase:
Study type: Observational

General adult healthy pregnant females in total 400, as well as their infants will be recruited. It is expected 67% will be vaginally delivered and 33% will be C Section deliveries. It is expected that of these groups that 40% of these women will be treated with antibiotics during their pregnancy. All C Section women (including emergency C Section) will be treated with IV Cefazolin at the time of incision, in theatre, to prevent internal wound infection. Primary objective The effect of maternal antibiotic administration during pregnancy upon the development of the intestinal microbiota until the age of two years; of C-section delivered infants compared to C-section delivered infants born to non-antibiotic treated pregnant women. To develop a cohort of vaginally delivered infants to isolate the 'missing microbes' (intestinal) in the groups above. Secondary objective The effect of maternal antibiotics on the developing infant by: - Anthropometric assessment: Body weight and Body length - Bayley scale of infant development test at age 2 years Ancillary - To isolate and characterise bacterial strains from fresh healthy infant faeces that are altered in the stools from C-section delivered and antibiotic treated infants and compared to vaginally delivered infants. - The effect of maternal antibiotic treatment on the human milk microbiome during lactation - Stress hormone levels of mothers and infants - Mental health questionnaire of mothers - Food frequency questionnaire of mothers Exploratory - To identify bacterial strains that can be further developed into probiotic products to help replenish depleted microbiota in the infant gut, born by C Section and or treated with antibiotics

NCT ID: NCT03834415 Completed - C-section Clinical Trials

Lactobacillus Reuteri DSM17938 in C-Section Infants

Start date: February 8, 2019
Phase: N/A
Study type: Interventional

RCT designed to evaluate the impact of Lactobacillus reuteri DSM17938 to modify gut microbiota in children delivered by C-section

NCT ID: NCT03176459 Completed - Pain Management Clinical Trials

Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections

C-Section
Start date: June 1, 2017
Phase: Phase 4
Study type: Interventional

Primary objective: The primary objective of this study is to compare total opioid consumption through 72 hours following EXPAREL+bupivacaine HCl infiltration into the transversus abdominis plane (TAP) after spinal anesthesia to active bupivacaine HCl TAP infiltration after spinal anesthesia in subjects undergoing an elective cesarean section (C-section). Secondary objective: The secondary objectives are to assess efficacy and safety parameters and patient satisfaction.

NCT ID: NCT02727452 Completed - C-Section Clinical Trials

Immediate Bonding and Caesarean Section

Start date: March 2016
Phase: N/A
Study type: Interventional

The randomised study analyzes the effects of immediate bonding (skin-to-skin contact) on different psychobiological and somatic outcomes of mother and child. The investigators compare 3 bonding conditions. Cortisol and Oxytocin are also measured during the bonding process.